search
Back to results

Spine Research With Roentgen Stereophotogrammetric Analysis (SpineRSA)

Primary Purpose

Spondylolisthesis, Degenerative Lumbar Disc Disease, Spinal Stenosis

Status
Completed
Phase
Phase 4
Locations
Canada
Study Type
Interventional
Intervention
Trabecular Metal Intervertebral Cage with RSA beads
Sponsored by
Nova Scotia Health Authority
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Spondylolisthesis focused on measuring Roentgen Stereophotogrammetric Analysis, Trabecular Metal Posterior Lumbar Interbody Cage, Posterior Lumbar Interbody Fusion Cage, Posterior Lumbar spine fusion surgery

Eligibility Criteria

20 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients must be at least 20 years of age
  • Clinical and radiologic history of spondylolisthesis (no greater than grade 1)
  • Spinal stenosis for which conservative treatment has failed
  • Degenerative disc disease, characterized by one or more of the following:

    • instability (defined as angular motion > 5° and/or translation > 4mm, based on Flex/Ext radiographs)
    • osteophyte formation
    • decreased disc height
    • thickening of ligamentous tissue
    • disc degeneration or herniation
    • facet joint degeneration

Exclusion Criteria:

  • Fusion at more than one level
  • Non-fusion surgery at the involved level
  • Previously diagnosed with osteopenia, osteoporosis, or osteomalacia to a degree that spinal instrumentation would be contraindicated
  • Patients with a highly-communicable disease, inflammatory or auto-immune based joint disease
  • Those with a history of endocrine or metabolic disorders known to affect osteogenesis (e.g. Paget's disease, renal osteodystrophy, Ehlers-Danios syndrome or osteogenesis imperfecta)
  • Patients with a documented titanium or tantalum alloy allergy or intolerance
  • Patients currently receiving active treatment for cancer or treatment with steroids such as cortisone
  • Patients with significant medical history that, in the Investigator's opinion, would not make them a good study candidate

Sites / Locations

  • Capital District Health Authority, QEII Health Sciences Centre,& Dalhousie University

Outcomes

Primary Outcome Measures

Spinal fusion and the rate of fusion and maintenance of spinal alignment will be assessed

Secondary Outcome Measures

Subjective outcome questionnaires will be used to characterize the patient sample used for the study to allow for comparisons to other treatments for this condition in the future.

Full Information

First Posted
June 27, 2007
Last Updated
February 18, 2013
Sponsor
Nova Scotia Health Authority
Collaborators
Zimmer Biomet
search

1. Study Identification

Unique Protocol Identification Number
NCT00493558
Brief Title
Spine Research With Roentgen Stereophotogrammetric Analysis
Acronym
SpineRSA
Official Title
A Consecutive Case Series of One-Level Lumbar Fusions With Pedicle Screw Instrumentation and the Trabecular Metal™ Intervertebral Cage Using Roentgen Stereophotogrammetric Analysis (RSA)
Study Type
Interventional

2. Study Status

Record Verification Date
February 2013
Overall Recruitment Status
Completed
Study Start Date
July 2007 (undefined)
Primary Completion Date
June 2012 (Actual)
Study Completion Date
June 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Nova Scotia Health Authority
Collaborators
Zimmer Biomet

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to gather information on the effectiveness of a new spine implant for patients who require spinal fusion surgery. Based on this information, we hope to create a standard of good performance, or benchmark, against which future studies on this spine implant can be compared. By creating this benchmark we hope to improve care for patients who require spinal fusion surgery.
Detailed Description
For patients in whom a spinal fusion is indicated, the posterior lumbar interbody fusion (PLIF) may be recommended to restore stability to the affected spinal segment1. Pioneered by a Dr.Cloward in the 1940s to treat painful intervertebral discs damaged by degeneration, PLIF involves removal of the entire nuclear portion of the disc and subsequent replacement with multiple blocks of transplanted bone. The purpose of the fusion is to eliminate or reduce the amount of the motion at the affected site, and, therefore, the source of pain. Four major intervertebral cages have been approved by the Food and Drug Administration (FDA) for use in humans: the Brantigan Interbody fusion Cage, the Ray Threaded Fusion Cage, the Bagby and Kuslich cage, and, most recently, the Trabecular Metal™ Cage. Comprised of 98 percent tantalum and 2 percent vitreous carbon, Trabecular Metal™ has the highest coefficient of friction of any implant material on the market, allowing for optimal initial implant-bone fit. Furthermore, the unique porous structure of Trabecular Metal™ provides significantly more space for tissue ingrowth to occur, facilitating a more cohesive implant-bone interface as well as long-term stability of the implant. Long-term follow up data on the efficacy of the Brantigan Interbody fusion cage, Ray Threaded Fusion cage, and Bagby and Kuslich cages are limited, with the most rigorous studies (i.e. controlled prospective studies) typically providing outcomes approximately 2 years post-surgery. Overall, these studies show that, while existing intervertebral cages have made significant advances in terms of addressing the disadvantages associated with traditional bone grafting/fixation techniques, problems continue to persist. Through comprehensive and accurate clinical evaluation of the Trabecular Metal™ intervertebral cage, the Research Team hopes to document advances in the PLIF technique, thereby informing current research as well as clinical practice. The primary goal of the proposed research is to gather data on the clinical efficacy of the Trabecular Metal™ Posterior Lumbar Interbody Fusion (PLIF) cage with pedicle screw instrumentation for the treatment of one-level lumbar spine fusions. Based on this pilot data, we hope to establish a level of acceptable clinical performance for the Trabecular Metal™ cage, a benchmark against which subsequent investigations can be compared. Direct surgical exploration is considered the most reliable method for accurately determining fusion success, both from a structural and functional perspective, following spinal fusion surgery. Unfortunately, this method is highly invasive, costly and seldom used. Furthermore, surgical exploration does not provide any longitudinal information as to the stability of the implant, including the monitoring of any occurrence of migration. In contrast, Roentgen Stereophotogrammetric Analysis(RSA)can detect the presence or absence of mobility between intervertebral segments (i.e. functional stability of the fusion) with a high degree of accuracy. RSA is a radiographic technique that uses small tantalum balls implanted into the patient's bone to measure micromotion (<1 mm) at the bone - implant interface, something which is not possible to do reliably using regular x-ray techniques. RSA provides a method for detecting inferior implant designs or cement formulations using only a small number of patients before release of these products into large clinical trials. RSA has been in use for several decades,and its safety is well documented.A computerized, digital RSA system has recently been installed and calibrated at our center. Its measurement capabilities have been rigorously validated, and it is currently being used to assess a new knee implant design. Expansion of the system to include spine RSA can be easily accomplished.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spondylolisthesis, Degenerative Lumbar Disc Disease, Spinal Stenosis
Keywords
Roentgen Stereophotogrammetric Analysis, Trabecular Metal Posterior Lumbar Interbody Cage, Posterior Lumbar Interbody Fusion Cage, Posterior Lumbar spine fusion surgery

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
17 (Actual)

8. Arms, Groups, and Interventions

Intervention Type
Device
Intervention Name(s)
Trabecular Metal Intervertebral Cage with RSA beads
Intervention Description
Roentgen Stereophotogrammetric Analysis beads will be inserted at time of implant of the Trabecular Metal Intervertebral Cage.
Primary Outcome Measure Information:
Title
Spinal fusion and the rate of fusion and maintenance of spinal alignment will be assessed
Time Frame
6 weeks, 3, 6, 12, and 24months.
Secondary Outcome Measure Information:
Title
Subjective outcome questionnaires will be used to characterize the patient sample used for the study to allow for comparisons to other treatments for this condition in the future.
Time Frame
3, 6, 12, 24 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients must be at least 20 years of age Clinical and radiologic history of spondylolisthesis (no greater than grade 1) Spinal stenosis for which conservative treatment has failed Degenerative disc disease, characterized by one or more of the following: instability (defined as angular motion > 5° and/or translation > 4mm, based on Flex/Ext radiographs) osteophyte formation decreased disc height thickening of ligamentous tissue disc degeneration or herniation facet joint degeneration Exclusion Criteria: Fusion at more than one level Non-fusion surgery at the involved level Previously diagnosed with osteopenia, osteoporosis, or osteomalacia to a degree that spinal instrumentation would be contraindicated Patients with a highly-communicable disease, inflammatory or auto-immune based joint disease Those with a history of endocrine or metabolic disorders known to affect osteogenesis (e.g. Paget's disease, renal osteodystrophy, Ehlers-Danios syndrome or osteogenesis imperfecta) Patients with a documented titanium or tantalum alloy allergy or intolerance Patients currently receiving active treatment for cancer or treatment with steroids such as cortisone Patients with significant medical history that, in the Investigator's opinion, would not make them a good study candidate
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dr. Wm Oxner, M.D.
Organizational Affiliation
Capital District Health Authority, QEII Health Science Centre, & Dalhousie University, Halifax. Nova Scotia,Canada
Official's Role
Principal Investigator
Facility Information:
Facility Name
Capital District Health Authority, QEII Health Sciences Centre,& Dalhousie University
City
Halifax
State/Province
Nova Scotia
ZIP/Postal Code
B3H-3A7
Country
Canada

12. IPD Sharing Statement

Learn more about this trial

Spine Research With Roentgen Stereophotogrammetric Analysis

We'll reach out to this number within 24 hrs